Document is current
Any future updates will be listed below
-
Authors
Di Maio, Danilo
Mitchell, S. A.
Batson, S.
Keeney, E.
Thom, Howard H. Z.
-
Funding
Funding for this research was provided by:
Roche
- License Information
-
More Information
Article History
Received: 1 July 2024
Accepted: 2 January 2025
First Online: 1 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: DDM is an employee of, and is an equity holder in, F. Hoffmann-La Roche Ltd. SM and SB are employees of Mtech Access, who received consultancy payments from F. Hoffmann-La Roche Ltd for the purposes of this study. EK is an employee of Clifton Insight who have received consultancy fees from Pfizer, Roche, Lundbeck, Amicus, Bayer, Merck, Eisai, Novo Nordisk, Novartis, and Daiichi-Sankyo. HT is an equity holder in Clifton Insight who have received consultancy fees from Pfizer, Roche, Lundbeck, Amicus, Bayer, Merck, Eisai, Novo Nordisk, Novartis, and Daiichi-Sankyo.
